Skip to content

Advice Protocol to Reduce the Level of Exposure to Metallic Trace Elements (ETM)

Prospective Evaluation of the Effectiveness of a Counseling Protocol to Reduce the Level of Exposure to Metallic Trace Elements (ETM)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05144438
Acronym
ETM
Enrollment
185
Registered
2021-12-03
Start date
2021-01-03
Completion date
2022-09-30
Last updated
2022-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metallic Trace Elements, Metal-type Environmental Pollutants

Brief summary

A French company (Toxseek, France, has developed a scientifically validated screening test based on a capillary determination of pollutants on a 3 cm lock of hair. The results of this screening allow physicians to discuss with their patients the question of environmental health and provide them with personalized behavioral advice in an attempt to eliminate the source of the pollutants identified.The main objective of the study is to assess the effectiveness of behavioral counseling on reducing the level of exposure to metal-type environmental pollutants (MTE) in pregnant women or women planning to have children.

Interventions

DIAGNOSTIC_TESTToxseek test

Hair taking

Sponsors

European Clinical Trial Experts Network
CollaboratorOTHER
Elsan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women over 18 years old * Patient with desire to conceive * 1st trimester of pregnancy * Patient having been informed of the study and not opposing the use of the data collected * Affiliate or beneficiary of a social security scheme

Exclusion criteria

* Women under 18 years old * 2nd and 3rd trimester of pregnancy * Patient objecting to the use of the data collected * Protected patient: adult under tutorship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients who reduced their level of exposure within 4 months of metal avoidance advice.4 monthsThe patient will be considered successful for the reduction of the exposure level, if all the metals with a risky exposure level during the 1st screening have gone to an exposure level to be monitored or acceptable during the 2nd screening.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026